Erbach, Germany

Hans-Ludwig Schafer

This inventor holds 1 USPTO granted patent. Top assignee: Steigerwald Arzneimittelwerk Gmbh. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Ludwig Schafer. Retrieved from https://idiyas.com/inventor/hans-ludwig-schafer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hans-Ludwig Schafer

Introduction

Hans-Ludwig Schafer is a notable inventor based in Erbach, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of hyperlipidaemia and atherosclerosis. His work has led to the development of a patented medicament that addresses these health issues.

Latest Patents

Hans-Ludwig Schafer holds 1 patent for his invention, which focuses on a medicament for the treatment of hyperlipidaemia and/or atherosclerosis. This innovation showcases his commitment to improving health outcomes through scientific advancements.

Career Highlights

Schafer is associated with Steigerwald Arzneimittelwerk GmbH, a company dedicated to pharmaceutical development. His role there has allowed him to work on groundbreaking research and contribute to the company's mission of enhancing health through innovative solutions.

Collaborations

One of his notable collaborators is Werner Schneider. Together, they have worked on various projects that aim to push the boundaries of medical science and improve patient care.

Conclusion

Hans-Ludwig Schafer's contributions to the field of medicine through his patent and collaboration with colleagues highlight his dedication to innovation. His work continues to impact the treatment of significant health conditions, showcasing the importance of inventors in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…